EHRA Premium Access

Ranolazine – mechanism and clinical results in AF.

Presentation

About the speaker

Associate Professor Gaetano Maria De Ferrari

Department of Molecular Medicine, Section of Cardiology, University of Pavia and Cardiac Intensive C, Pavia (Italy)
14 presentations
0 follower

3 more presentations in this session

The current role of Dronedarone.

Speaker: Professor S. Hohnloser (Frankfurt, DE)

Thumbnail

Atrial-specific antiarrhythmic agents.

Speaker: Doctor S. Nattel (Montreal, CA)

Thumbnail

Non anti arrhythmic pharmacological therapy for maintenance of sinus rhythm.

Speaker: Doctor I. Savelieva (London, GB)

Thumbnail

Access the full session

Pharmacological therapy in AF

Speakers: Associate Professor G. De Ferrari, Professor S. Hohnloser, Doctor S. Nattel, Doctor I. Savelieva
Thumbnail

About the event

Image

EHRA EUROPACE - CARDIOSTIM 2017

18 June - 21 June 2017

Sessions Presentations

Related content

ESC Premium Access

Antiplatelet therapy and outcome in patients with COVID-19. Results from a multi-center international prospective registry (HOPE-COVID19).

29 August 2021

ESC Premium Access

Myocardial ischaemia of non-obstructive origin as a cause of new onset anginal chest pain in the long COVID syndrome

29 August 2021

ESC Premium Access

A prospective evaluation of COVID-19 associated coagulopathy with acute coronary syndrome (ACS)

29 August 2021

This platform is supported by

logo Novo Nordisk